Opportunity to Realise the Value of Dormant UK Authorisations before December Deadline
October 19, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Holders wishing to cancel their authorisations, registrations and licences are required to notify the MHRA by 31 December 2011 to …
GSK malaria vaccine cuts disease risk by half
October 19, 2011Research and Development malaria, malaria vaccine
Results from GSK’s malaria vaccine trial have excited observers after it reduced the risk of the disease by half. Data …
European judge rules against stem cell patents
October 19, 2011Research and Development Stem cells, patents
The European Court of Justice has ruled that stem cells cannot be patented, representing a major blow to research in …
NHS hospital prescribing costs jump
October 19, 2011Sales and Marketing hospital spending, prescribing
New and expensive treatments have driven up NHS prescribing costs in English hospitals, according to a new report. IMS Health …
German biotech Apceth appoints Prof. Ralf Huss
October 19, 2011Research and Development appointment, research and development
Munich-based biotech Apceth has appointed Prof Ralf Huss to its management board. Prof Huss moves to the company from Roche, …
Digital Pharma: It’s not about the brand website
October 19, 2011Sales and Marketing Digital Pharma blog
The last few years have seen an explosion of interest in digital marketing in the pharma sector, reflecting the wider …
Byetta approved for use with insulin
October 19, 2011Amylin, GLP-1, diabetes, lilly
The FDA has approved the use of Lilly and Amylin’s diabetes treatment Byetta as an add-on therapy to insulin glargine.The …
Lundbeck establishes research centre in China
October 18, 2011Research and Development Brain disorders, CNS, China, Lundbeck, Shanghai, emerging markets
Lundbeck has set up a new research centre in China, joining a wave of pharma companies investing in the region. The …
KV Pharma sues ex-chief exec to recoup compensation package
October 18, 2011Ethex, KV Pharma, Marc Hermelin
US drugmaker KV Pharmaceutical is suing its former chief executive Marc Hermelin to avoid paying him a retirement and compensation …
GSK planning job cuts at Quebec vaccines plant
October 18, 2011Manufacturing and Production Canada, GSK, Quebec, vaccines
GlaxoSmithKline has decided to cut around 9% of its workforce in Quebec City, Canada, with a vaccines manufacturing plant bearing …
Angel Bio plans joint venture with Russian drugmaker
October 18, 2011Manufacturing and Production Angel Biotechnology, Materia Medica, Russia, biologics
UK contract manufacturing organisation Angel Biotechnology has agreed to set up a joint venture with Russian counterpart Materia Medica Holding …
NICE recommends Lilly’s long-acting Bydureon
October 18, 2011Sales and Marketing Bydureon, NICE, diabetes
NICE has recommended Eli Lilly’s long-acting diabetes drug Bydureon after the failure of oral treatments. Bydureon (exenatide) – a long-acting …
Grant nominated for key NHS Commissioning Board post
October 18, 2011Commissioning Board, Malcolm Grant, NHS, Nicholson
The government has named its choice for one of the key roles at the new NHS Commissioning Board. Professor Malcolm …
EMA resources stretched by Mediator scandal
October 18, 2011Research and Development, Sales and Marketing EMA, Mediator
The European Medicines Agency has been forced to use ‘considerable resources’ to deal with a flood of enquiries over Mediator …
Pharma Brands – join the live discussion on Twitter
October 17, 2011Sales and Marketing branding, brands
Do pharma marketers need to kill off the ‘smiley happy people’ and update their approach to branding? InPharm will host …
Roche buys US firm Anadys for $230 million
October 17, 2011Research and Development, Sales and Marketing Roche, hepatitis C
Roche has acquired US firm Anadys for $230 million, bolstering its infectious drugs pipeline. California-based Anadys develops oral, small molecule …
Russian diabetes market to grow to $1.7 billion
October 17, 2011Sales and Marketing Russia, diabetes
Russia’s diabetes market is set be worth $1.7 billion by 2015, according to a new report. Industry analysts Decision Resources’ …
Frontera appoints creative director
October 14, 2011Medical Communications appointment, medical communications
Covent Garden-based comms agency Frontera has appointed Bruno Cepollina as creative director. The former creative partner at McCann Healthcare is …
Health service’s £1bn patent expiry windfall
October 14, 2011Sales and Marketing generics, patent expiry
Patent expiries could shave £1 billion from the NHS drugs bill, and could yield major savings by 2015 for the …
Pfizer to research prescription drug costs for the elderly
October 14, 2011Sales and Marketing Pfizer
Pfizer has signed a five-year research pact with US healthcare insurer Humana to investigate treatment costs for the elderly. The …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
